1. Novel molecular signatures and potential therapeutics in renal cell carcinomas: Insights from a comparative analysis of subtypes
   Aysegul Caliskan et al, 2020, Genomics CrossRef
2. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort
   Jeff Johnson et al, 2016, Oncotarget CrossRef
3. The transformics assay: first steps for the development of an integrated approach to investigate the malignant cell transformation in vitro
   Maria Grazia Mascolo et al, 2018, Carcinogenesis CrossRef
4. Renal toxicity of Aconitum plants? A study based on a new mass spectrometry scanning strategy and computer virtual screening
   Yihui Yin et al, 2024, Phytochemical Analysis CrossRef
5. PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype
   Stefano Lucà et al, 2023, Cancers CrossRef
6. PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas
   Annalisa Passariello et al, 2019, Cancers CrossRef
7. FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles
   Zhi Yang et al, 2017, Therapeutic Advances in Medical Oncology CrossRef
8. FOXC1: an emerging marker and therapeutic target for cancer
   B Han et al, 2017, Oncogene CrossRef
9. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach
   Md. Rabiul Auwul et al, 2021, Saudi Journal of Biological Sciences CrossRef
10. Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for EGR2 in tumorigenesis
    Joseph L. Regan et al, 2022, iScience CrossRef
11. The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes
    Xingen Wang et al, 2019, Cancer Research and Treatment CrossRef
12. System biology approaches identified novel biomarkers and their signaling pathways involved in renal cell carcinoma with different human diseases
    Md. Saddam Hossen et al, 2022, Bioscience Reports CrossRef
13. Genetic alteration of histone lysine methyltransferases and their significance in renal cell carcinoma
    Libin Yan et al, 2019, PeerJ CrossRef
14. The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement
    Monica Fedele et al, 2017, International Journal of Molecular Sciences CrossRef
15. Genome-wide meta-analysis identifies new candidate genes for sickle cell disease nephropathy
    Melanie E. Garrett et al, 2023, Blood Advances CrossRef
16. RegulatorTrail: a web service for the identification of key transcriptional regulators
    Tim Kehl et al, 2017, Nucleic Acids Research CrossRef
17. Integrated mendelian randomization analyses highlight AFF3 as a novel eQTL-mediated susceptibility gene in renal cancer and its potential mechanisms
    Qiming Wang et al, 2024, BMC Cancer CrossRef
18. Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis
    Tania Ray et al, 2021, Frontiers in Oncology CrossRef
19. Transcriptomics in RCC
    Jamil S. Syed et al, 2020, Urologic Oncology: Seminars and Original Investigations CrossRef